• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建模慢性红细胞输注导致的血红蛋白增量损失。

Modelling haemoglobin incremental loss on chronic red blood cell transfusions.

机构信息

PC Insights, Barrington, Illinois, USA.

Hemanext Inc, Lexington, Massachusetts, USA.

出版信息

Vox Sang. 2022 Jun;117(6):831-838. doi: 10.1111/vox.13261. Epub 2022 Mar 2.

DOI:10.1111/vox.13261
PMID:35238052
Abstract

BACKGROUND AND OBJECTIVES

Understanding the impact of red blood cell (RBC) lifespan, initial RBC removal, and transfusion intervals on patient haemoglobin (Hb) levels and total iron exposure is not accessible for chronic transfusion scenarios. This article introduces the first model to help clinicians optimize chronic transfusion intervals to minimize transfusion frequency.

MATERIALS AND METHODS

Hb levels and iron exposure from multiple transfusions were calculated from Weibull residual lifespan distributions, the fraction effete RBC removed within 24-h (X ) and the nominal Hb increment. Two-unit transfusions of RBCs initiated at patient [Hb] = 7 g/dl were modelled for different RBC lifespans and transfusion intervals from 18 to 90 days, and X from 0.1 to 0.5.

RESULTS

Increased X requires shorter transfusion intervals to achieve steady-state [Hb] of 9 g/dl as follows: 30 days between transfusions at X  = 0.5, 36 days at X  = 0.4, 42 days at X  = 0.3, 48 days at X  = 0.2 and 54 days at X  = 0.1. The same transfusion interval/X pairs result in a steady-state [Hb] = 8 g/dl when the RBC lifespan was halved. By reducing transfused RBC increment loss from 30% to 10%, annual transfusions were decreased by 22% with iron addition decreased by 24%. Acute dosing of iron occurs at the higher values of X on the day after a transfusion event.

CONCLUSION

Systematic trends in fractional Hb incremental loss X have been modelled and have a significant and calculatable impact on transfusion intervals and associated introduction of iron.

摘要

背景与目的

对于慢性输血情况,了解红细胞(RBC)寿命、初始 RBC 清除率和输血间隔对患者血红蛋白(Hb)水平和总铁暴露的影响是无法实现的。本文介绍了第一个模型,以帮助临床医生优化慢性输血间隔,以最大程度地减少输血频率。

材料与方法

使用威布尔剩余寿命分布、24 小时内去除的无效 RBC 分数(X)和名义 Hb 增加值计算多次输血后的 Hb 水平和铁暴露量。以患者 [Hb] = 7 g/dl 为起点,对不同 RBC 寿命和输血间隔(18 至 90 天)以及 X(0.1 至 0.5)进行了两单位 RBC 输血建模。

结果

增加 X 需要更短的输血间隔才能达到 9 g/dl 的稳态 [Hb],具体如下:X = 0.5 时输血间隔为 30 天,X = 0.4 时为 36 天,X = 0.3 时为 42 天,X = 0.2 时为 48 天,X = 0.1 时为 54 天。当 RBC 寿命减半时,相同的输血间隔/X 对会导致稳态 [Hb] = 8 g/dl。通过将输血 RBC 增量损失从 30%降低到 10%,每年的输血次数减少了 22%,同时铁的补充减少了 24%。输血后第二天,X 的较高值会导致急性铁剂量发生。

结论

已对 X(Hb 增量损失的分数)的系统性趋势进行了建模,这对输血间隔和相关铁的引入具有显著且可计算的影响。

相似文献

1
Modelling haemoglobin incremental loss on chronic red blood cell transfusions.建模慢性红细胞输注导致的血红蛋白增量损失。
Vox Sang. 2022 Jun;117(6):831-838. doi: 10.1111/vox.13261. Epub 2022 Mar 2.
2
Patient blood transfusion management: discharge hemoglobin level as a surrogate marker for red blood cell utilization appropriateness.患者输血管理:出院血红蛋白水平作为红细胞利用适宜性的替代指标。
Transfusion. 2012 Nov;52(11):2445-51. doi: 10.1111/j.1537-2995.2012.03591.x. Epub 2012 Mar 13.
3
Posttransfusion recovery of stored red blood cells in very low birth weight infants using a hemoglobin balance model.使用血红蛋白平衡模型评估极低出生体重儿输注储存红细胞后的恢复情况
Transfusion. 2004 Jul;44(7):1019-24. doi: 10.1111/j.1537-2995.2004.03376.x.
4
Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.重症监护病房中感染性休克患者红细胞输血的益处与危害
Dan Med J. 2016 Feb;63(2).
5
Triggers and appropriateness of red blood cell transfusions in the postpartum patient--a retrospective audit.产后患者红细胞输注的触发因素和适宜性——回顾性审核。
Vox Sang. 2010 Jan;98(1):65-9. doi: 10.1111/j.1423-0410.2009.01231.x. Epub 2009 Aug 17.
6
Haemoglobin thresholds for transfusion: how are we doing in the era of Choosing Wisely? A retrospective cohort study.输血的血红蛋白阈值:在明智选择的时代我们做得如何?一项回顾性队列研究。
Swiss Med Wkly. 2023 Nov 29;153:40132. doi: 10.57187/smw.2023.40132.
7
Cytokine profiling and post-transfusion haemoglobin increment in patients with haematological diseases.血液系统疾病患者的细胞因子分析及输血后血红蛋白增加情况
Vox Sang. 2018 Oct;113(7):657-668. doi: 10.1111/vox.12703. Epub 2018 Aug 29.
8
Red blood cell utilization and transfusion triggers in patients diagnosed with chronic lymphocytic leukaemia in Iceland 2003-2016.2003-2016 年冰岛诊断为慢性淋巴细胞白血病患者的红细胞利用和输血触发因素。
Vox Sang. 2019 Jul;114(5):495-504. doi: 10.1111/vox.12775. Epub 2019 Mar 29.
9
Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).法国贫血癌症患者中铁蔗糖和红细胞输血的使用情况(OncoFer研究)。
Support Care Cancer. 2017 Mar;25(3):973-982. doi: 10.1007/s00520-016-3489-3. Epub 2016 Dec 3.
10
Impact of Hemoglobin Drop, Bleeding Events, and Red Blood Cell Transfusions on Long-term Mortality in Patients Undergoing Transaortic Valve Implantation.血红蛋白下降、出血事件及红细胞输注对接受经导管主动脉瓣植入术患者长期死亡率的影响
Can J Cardiol. 2016 Oct;32(10):1239.e9-1239.e14. doi: 10.1016/j.cjca.2015.10.032. Epub 2015 Nov 10.